JESSICA GARNIER: Open Payments
NPI 1760959118 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 26 payments from 10 companies in 2025. Trend: 2023 $1,082 · 2024 $488 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $204 |
| Lundbeck LLC | 2 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $45 |
| Alkermes, Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Janssen Biotech, Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
Products named: VRAYLAR, BOTOX, REXULTI, AUSTEDO XR, SPRAVATO, LYBALVI, ABILIFY MAINTENA, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
